Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Constella“
Suchtreffer
Begriffe & Kennungen
Constella
Eintrag öffnenConstella · 4.1 Therapeutic indications · 1
Eintrag öffnenConstella · 4.3 Contraindications · 1
Eintrag öffnenConstella · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenConstella · 4.3 · Patients with known or suspected mechanical gastrointestinal obstruction.
Eintrag öffnenConstella · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenConstella · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenConstella · 4.5 · A food interaction clinical study in healthy subjects showed that linaclotide was not detectable in plasma eit
Eintrag öffnenConstella · 4.5 · Concomitant treatment with proton pump inhibitors, laxatives or NSAIDs may increase the risk of diarrhoea. Cau
Eintrag öffnenConstella · 4.5 · In cases of severe or prolonged diarrhoea, absorption of other oral medicinal products may be affected. The ef
Eintrag öffnenConstella · 4.5 · No interaction studies have been performed. Linaclotide is rarely detectable in plasma following administratio
Eintrag öffnenConstella · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenConstella · 4.8 Undesirable effects · 1
Eintrag öffnenConstella · 4.8 · 4 Table 1 Adverse reactions reported in clinical studies and from post-marketing experience at the recommended
Eintrag öffnenConstella · 4.8 · Description of selected adverse reactions Diarrhoea is the most common adverse reaction and is consistent with
Eintrag öffnenConstella · 4.8 · Elderly (>65 years), hypertensive and diabetic patients reported diarrhoea more frequently as compared to the
Eintrag öffnenConstella · 4.8 · MedDRA Very system organ Common Uncommon Rare Not known common class Infections and Gastroenteritis infestatio
Eintrag öffnenConstella · 4.8 · Other common adverse reactions (>1%) were abdominal pain, abdominal distension and flatulence.
Eintrag öffnenConstella · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenConstella · 4.8 · Summary of the safety profile Linaclotide has been given orally to 1 166 patients with IBS-C in controlled cli
Eintrag öffnen